The Asia Pacific L-Carnitine Market would witness market growth of 5.38% CAGR during the forecast period (2019-2025).
The product is used to help people with low natural L-carnitine levels. Deficiency can occur due to several factors like genetic disorders, drug use, and medical conditions such as skeletal myopathies. These factors increased the demand for L-carnitine as dietary supplements exclusively. In addition, growing concerns about the quality and safety of meat have stimulated the use of animal feed supplements. L-carnitine is used as a supplement in animal feed and is likely to bring various benefits including growth efficiency and improved process of reproduction. It is used to feed various domestic animals like cows, pigeons, racing horses, and pigs to increase their average rate of gain and daily performance and growth. The growth of the animal feed industry is expected to increase the demand for L-carnitine in the years to come.
It is expected that technological advances in manufacturing techniques would play a major role in boosting the market growth. It is expected that uncertainty in the manufacturing process and misleading advertisements promoting hyped product benefits would hamper the market growth. Due to an excessive amount of waste and wastewater generated through the manufacturing processes, the market is also likely to face regulatory restrictions.
Based on Product, the market is segmented into Food & Pharma Grade and Feed Grade. Based on Process, the market is segmented into Chemical Synthesis and Bioprocess. Based on Application, the market is segmented into Healthcare Product, Functional Drink, Medicine and Animal Food. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.
Scope of the Study
- Food & Pharma Grade
- Feed Grade
- Chemical Synthesis
- Healthcare Product
- Functional Drink
- Animal Food
- South Korea
- Rest of Asia Pacific
- Merck Group
- Lonza Group AG
- Northeast Pharmaceutical Group Co. Ltd.
- Cayman Chemical Company, Inc.
- Tokyo Chemical Industry Co. Ltd.
- Ceva Sante Animale S.A.
- Kaiyuan Hengtai Chemical Co., Ltd.
- ChengDa Pharmaceuticals Co., Ltd.
- HuangGang HuaYang Pharmaceutical Co., Ltd.
- HuBei YuanCheng SaiChuang Technology Co. Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free